Also, how can the company be actively raising $15 million in new money without a filing about it? Is it covered by some other previous shelf filing? Shouldn't we at least have a press release on that. And if they couldn't raise $15 million with a more attractive convertible offering, how are they going to raise it with a less attractive stock/warrant offering?
Fred, I think that if the offering is an exempt offering under Reg D, then all the company has to do is file Form D within 15 days of the first sale. CYDY filed this same form back on 6-14-17 I think. I expect we'll see another one in the next several weeks.
Also, my thoughts regarding your second question are that they closed the prior offering at the end of July before releasing the last two PR's.
Since the time the last offering closed, CYDY has confirmed that combo is fully enrolled and has provided a compelling update regarding 11 of the 34 patients that have completed the 25-week study. Still a lot of uncertainty here, but maybe there is less than when they closed the last offering on 7-31 (or whenever it was). That could explain how they think they can raise more now on less attractive terms to potential investors.